---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-116962"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-11-28T23:59:59+00:00"
generated_at: "2026-05-16T16:02:12.867027+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma shareholders approve 1.5M share increase to incentive plan and elect directors

## Summary
- Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 1,500,000 and extending term to November 20, 2035.
- Seven directors elected: Iain Dukes, Werner Cautreels, Trafford Clarke, John Leaman, Nikolay Savchuck, M. Teresa Shoemaker, Jack E. Stover.
- Advisory vote on executive compensation approved; company will hold such votes every two years, next at 2027 annual meeting.
- Ratification of KPMG as independent auditor for FY2025 approved with 3,350,178 votes for.

## SEC filing metadata
- accession: 0001104659-25-116962
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925116962/0001104659-25-116962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925116962/tm2532319d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-116962
- JSON: https://secwatch.observer/filing/0001104659-25-116962.json
- Plain text: https://secwatch.observer/filing/0001104659-25-116962.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.